Naltrexone News and Research

RSS

Wistar awarded more than $12 million to study opioid use in HIV-infected people

The Wistar Institute was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse, part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by Wistar's HIV Research Program.

24 Sep 2019

Review highlights medication underuse in the treatment of opioid use disorder

Though research shows that medication-assisted treatment can help people who are addicted to opioids, the three drugs approved by the Food and Drug Administration (FDA) are underused, according to a review of current medical data on opioid addiction in the U.S.

19 Sep 2019

Reducing opioid overdose risk in incarcerated women after prison release

More than 75 percent of incarcerated women in Oregon's state prison system require treatment for a substance use disorder.

11 Sep 2019

Teens with severe opioid use disorder can be treated with medications

Teens who misuse prescription or illicit opioids might benefit from opioid treatment medications, according to a new study led by a Yale researcher.

11 Sep 2019

Psychopathy associated with robust alterations in expression of genes, study shows

The expression of many genes that have previously been associated with autism is abnormal also in violent psychopathy, a new study shows.

30 Aug 2019

Front-line primary care providers given tools to play larger role in tackling opioid abuse

Buprenorphine and naltrexone can help break a person's addiction to life-threatening opioid use disorder, but they can be hard for front-line, primary care providers to prescribe, according to researchers at McGovern Medical School at The University of Texas Health Science Center.

27 Aug 2019

Patients who start long-term buprenorphine treatment are less likely to use opioids

In a first-ever randomized trial, patients at a short-term inpatient program began long-term outpatient treatment with buprenorphine before discharge, with better outcomes than detox patients.

21 Aug 2019

Drug used to treat alcohol use disorder reduces craving in heavy drinkers

Researchers at Yale University have identified how naltrexone, a medication used to treat alcohol use disorder, reduces craving and consumption in heavy drinkers.

6 Aug 2019

Evidence shows ketamine is not opioid and can treat depression easily

Ketamine’s reputation as an antidepressant is restored; it’s not an opioid.

From Johns Hopkins Medicine 1 Aug 2019

Researchers receive $10 million grant to examine opioid addiction treatment for jail detainees

Researchers at the University of Massachusetts Amherst and the University of Massachusetts Medical School are among the scientists at a dozen institutions nationwide that will form the Justice Community Opioid Innovation Network, an ambitious, $155 million effort to improve opioid addiction treatment in criminal justice settings, the National Institutes of Health announced.

25 Jul 2019

Alcohol reduction associated with improved viral suppression in women living with HIV

Women living with HIV are less likely than men to achieve viral suppression with antiretroviral therapy.

11 Jul 2019

Medicare going in ‘right direction’ on opioid epidemic

Prescriptions for two drugs used to treat opioid addiction increased significantly from 2016 to 2018 for people on Medicare, according to a federal report out Wednesday.

10 Jul 2019

UM scientists receive $3.3 million NIH contract to develop opioid addiction vaccine

The University of Montana has received a $3.3 million contract from the National Institutes of Health to develop an innovative vaccine targeting opioid addiction.

10 Jul 2019

Study: Dozens of counties in the U.S. are at highest risk for opioid deaths

Dozens of counties in the Midwest and South are at the highest risk for opioid deaths in the United States, say University of Michigan researchers.

29 Jun 2019

FDA approves new drug to treat hypoactive sexual desire disorder in premenopausal women

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.

23 Jun 2019

Nurses play key role in promoting compassionate care for patients with alcohol use disorder

Nurses play a critical role in promoting compassionate care for patients and families affected by alcohol use disorder, including evidence-based medication-assisted treatment approaches, according to a paper in the July/September Journal of Christian Nursing, official journal of the Nurses Christian Fellowship.

12 Jun 2019

Naltrexone News and Research

Wistar awarded more than $12 million to study opioid use in HIV-infected people

Review highlights medication underuse in the treatment of opioid use disorder

Reducing opioid overdose risk in incarcerated women after prison release

Teens with severe opioid use disorder can be treated with medications

Psychopathy associated with robust alterations in expression of genes, study shows

Front-line primary care providers given tools to play larger role in tackling opioid abuse

Patients who start long-term buprenorphine treatment are less likely to use opioids

Drug used to treat alcohol use disorder reduces craving in heavy drinkers

Evidence shows ketamine is not opioid and can treat depression easily

Researchers receive $10 million grant to examine opioid addiction treatment for jail detainees

Alcohol reduction associated with improved viral suppression in women living with HIV

Medicare going in ‘right direction’ on opioid epidemic

UM scientists receive $3.3 million NIH contract to develop opioid addiction vaccine

Study: Dozens of counties in the U.S. are at highest risk for opioid deaths

FDA approves new drug to treat hypoactive sexual desire disorder in premenopausal women

Nurses play key role in promoting compassionate care for patients with alcohol use disorder

Use of buprenorphine to treat opioid addiction proliferates in California

Addiction medicine mostly prescribed to whites, even as opioid deaths rose among blacks

Naltrexone implant more effective in reducing relapses in HIV patients with opioid addiction

Discharged, dismissed: ERs often miss chance to set overdose survivors on ‘better path’

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News